+ Watch ICLR
on My Watchlist
The Company is a contract research organization, providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.
Discounted earnings valuation assuming 25% earnings growth over 10 years indicates this stock is selling at a substantial discount. Even assuming 20%, it's fairly priced. Just backed off a new high, buying on the dip. Healthcare sector will outperform.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions